NANJING PHARMACEUTICAL COMPANY LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.67 CNY | 0.00% |
|
-0.21% | -3.51% |
| Sales 2022 | 50.22B 6.94B | Sales 2023 | 53.59B 7.4B | Capitalization | 6.34B 876M |
|---|---|---|---|---|---|
| Net income 2022 | 596M 82.32M | Net income 2023 | 578M 79.84M | EV / Sales 2022 | 0.27 x |
| Net Debt 2022 | 6.94B 959M | Net Debt 2023 | 6.74B 931M | EV / Sales 2023 | 0.24 x |
| P/E ratio 2022 |
10.8
x | P/E ratio 2023 |
10.9
x | Employees | 4,903 |
| Yield 2022 |
2.73% | Yield 2023 |
3.31% | Free-Float | 41.55% |
More Fundamentals
* Assessed data
More news
| 1 week | -0.21% | ||
| Current month | +2.64% | ||
| 1 month | +1.74% | ||
| 3 months | +1.74% | ||
| 6 months | -6.41% | ||
| Current year | -3.51% |
1 week
4.45
4.71
1 month
4.434.76
Current year
3.855.03
1 year
3.856.45
3 years
3.856.45
5 years
3.856.45
10 years
3.8520.50
| Managers | Title | Age | Since |
|---|---|---|---|
Liang Zhang
PSD | President | 51 | 22-04-27 |
Xun Jie Luo
BRD | Director/Board Member | 56 | 17-08-16 |
Qing Yang
BRD | Director/Board Member | 53 | 11-12-24 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jian Jun Zhou
CHM | Chairman | 58 | 19-03-20 |
Qing Yang
BRD | Director/Board Member | 53 | 11-12-24 |
Jian Nan Xu
BRD | Director/Board Member | - | 21-04-25 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +1.25% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 4.67 | 0.00% | 8 424 468 |
| 24-04-18 | 4.67 | +1.30% | 9,744,896 |
| 24-04-17 | 4.61 | +3.60% | 10,090,370 |
| 24-04-16 | 4.45 | -3.26% | 12,543,370 |
| 24-04-15 | 4.6 | -1.08% | 11,539,490 |
End-of-day quote Shanghai S.E., April 18, 2024
More quotes
NanJing Pharmaceutical Company Limited is a China-based company principally engaged in the pharmaceutical distribution business. The Company's principal businesses include the pharmaceutical wholesale, pharmaceutical retail, pharmaceutical-Internet + business, as well as the pharmaceutical third-party logistics services. The Company mainly conducts its business in domestic market.
Sector
Pharmaceuticals
Calendar
2024-04-29
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -3.51% | 845M | |
| +13.36% | 68.18B | |
| +7.33% | 25.78B | |
| +6.34% | 7.99B | |
| -2.79% | 7.88B | |
| -24.02% | 7.62B | |
| +21.83% | 4.45B | |
| -2.28% | 3.89B | |
| -3.51% | 3.82B | |
| +25.02% | 3.69B |
- Stock Market
- Equities
- 600713 Stock
